Gara Jalqabaatti › Luukemiya Mayiloodii Faasii Keessummaa
Qorannoo klinikaalii Luukemiya Mayiloodii Faasii Keessummaa Ameerikaa Keessatti hirmaatuu
Qorannoo 11 Luukemiya Mayiloodii Faasii Keessummaa f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 5
- New York City, NYQorannoo 3
- Portland, ORQorannoo 3
- Seattle, WAQorannoo 3
- Birmingham, ALQorannoo 3
Naannoon
- AlabamaQorannoo 3
- CaliforniaQorannoo 5
- GeorgiaQorannoo 3
- New YorkQorannoo 5
- North CarolinaQorannoo 3
- OregonQorannoo 4
- TexasQorannoo 6
- WashingtonQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT01746836Study of Olverembatinib (HQP1351) in Patients With CML-CP
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06423911Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04838041Personalized NK Cell Therapy in CBT
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 15 hanga 80 · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT02727803A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07020533A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT07091019Registry of Older Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT01137825MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Namoota walitti qabaa jira
Umuriin 0 hanga 25 · Saalaa hunda · Haaromfame 13-Cam-2026 · NCT05794880A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Elb-2026 · NCT05304377Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT06229860A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Ama-2026 · NCT06163430Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.